Stock Groups

My Top Value Stock for the Week -Breaking

by Mike Robinson

[ad_1]

© Reuters. GlaxoSmithKline is my Top Value Stock of the Week

GlaxoSmithKline PLC is the largest pharmaceutical company in the world. It is a company that focuses on HIV vaccines and cancers. The firm has seen a lot success in recent years with the development of new drugs, as well as many others in its pipeline. The stock’s value is even lower than it was before, so investors might consider including it in their portfolios.GlaxoSmithKline PLC(*(GSK)It is the top-selling pharmaceutical company in terms of total revenue. It has a strong presence in a variety of therapeutic areas, such as oncology and respiratory. GSK has joint ventures that allow it to expand its reach in certain markets, such as HIV or consumer products. GSK is a good example of this.

Pfizer (NYSE:) The company merged its consumer healthcare division into a joint venture. GSK holds a 68% controlling interest in the venture. But, GSK is changing its plans for the consumer unit. It plans to separate itself into two independent companies.GSK will create a new biopharma company that focuses on the development of new treatments. GSK will separate the consumer healthcare section into its own company in 2019. GSK can now concentrate on drug discovery with this spin-off.

Disclaimer

Continue reading on StockNews

Fusion Media This website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media is not responsible for trading losses that may be incurred as a consequence of the use of this data.Fusion Media

Fusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.